Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

June 6, 1997

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

Cholesterol-lowering activity of squalene synthase inhibitor in animal models

June 5, 1997

Focus on drug interactions with a common food: grapefruit

June 5, 1997

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

AGE inhibitor described by Kissei

June 3, 1997

Positive efficacy profile reported for Zonagen's Vasomax

May 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...